Results 291 to 300 of about 425,993 (391)

Cost-benefit analysis of universal screening for HCV infection in China: a Markov modelling study. [PDF]

BMC Health Serv Res
Zhou D, Xu L, Zhong Y, Xu Z, Wang J, Wang Y, Gao Y, Xie J, Xia Y, Tang W.   +9 more
europepmc   +1 more source

Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology

, 1996
Jill Detmer, Robert Lagier, Jacqueline K. Flynn, C Zayati, Janice A. Kolberg, Micheál Collins, M. S. Urdea, Ray Sánchez-Pescador   +7 more
openalex   +1 more source

Sofosbuvir and Ledipasvir for 8 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in HCV-Monoinfected and HIV-HCV-Coinfected Individuals: Results From the German Hepatitis C Cohort (GECCO-01).

Clinical Infectious Diseases, 2016
P. Ingiliz, S. Christensen, Torben Kimhofer, D. Hueppe, T. Lutz, K. Schewe, H. Busch, G. Schmutz, M. Wehmeyer, C. Boesecke, K. Simon, F. Berger, J. Rockstroh, J. Schulze zur Wiesch, A. Baumgarten, S. Mauss   +15 more
semanticscholar   +1 more source

Prognostic Significance of Bile Duct Loss in Early‐Stage Primary Biliary Cholangitis: A Long‐Term Observational Study

Hepatology Research, EarlyView.
Bile duct loss on liver biopsy predicts future liver‐related events in early‐stage primary biliary cholangitis, even in patients with preserved liver function. This finding highlights the prognostic value of histological bile duct assessment at diagnosis and may guide early risk stratification and management decisions.
Taiki Okumura, Takefumi Kimura, Takanobu Iwadare, Shun‐Ichi Wakabayashi, Hiroyuki Kobayashi, Yuki Yamashita, Satoru Joshita, Michiharu Komatsu, Naoki Tanaka, Akihiro Matsumoto, Tomoyuki Nakajima, Mai Iwaya, Masahiro Umemura, Kazuhito Kawata, Kenichi Harada, Takeji Umemura   +15 more
wiley   +1 more source

Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India. [PDF]

BMC Infect Dis
Dutta S, Nath S, Das R, Bakshi S, Majumdar M, Ghosh A, Baskey U, Chowdhury PK, Sadhukhan PC.   +8 more
europepmc   +1 more source

Rechallenge of Atezolizumab Plus Bevacizumab Therapy in Patients With Unresectable Hepatocellular Carcinoma

Hepatology Research, EarlyView.
ABSTRACT Background Atezolizumab plus bevacizumab (AB) is a standard first‐line therapy for unresectable hepatocellular carcinoma (HCC). However, data on the efficacy and safety of AB rechallenge (re‐AB) after discontinuation are limited. Methods We conducted a retrospective analysis of 13 patients with unresectable HCC who received initial AB ...
Yuichiro Suzuki, Teiji Kuzuya, Leona Osawa, Yasuyuki Komiyama, Hitomi Takada, Shuya Matsuda, Masaru Muraoka, Mitsuaki Sato, Shinya Maekawa, Nobuyuki Enomoto, Hisanori Muto, Yoshihiko Tachi, Yoshiki Hirooka, Atsunori Tsuchiya   +13 more
wiley   +1 more source

HBV and HCV genome in peripheral blood mononuclear cells in patients undergoing chronic hemodialysis

, 1995
Christian Oesterreicher, Johann Hammer, Uwe Koch, Franz Pfeffel, Gere Sunder‐Plassmann, Dagmar Petermann, Christian Müller   +6 more
openalex   +1 more source

Mitochondrial Oxidative Stress in Circulating Leukocytes as a Prognostic Marker in Hepatocellular Carcinoma

Hepatology Research, EarlyView.
ABSTRACT Background and Aims The relationship between oxidative stress (OS) and hepatocellular carcinoma (HCC) is well known, influencing both, hepatocarcinogenesis and subsequent tumor progression. Less understood is its potential role in antitumor defense mechanisms.
Víctor Merino, Carlos Abril, Gloria Segarra, Maria Pilar Ballester, Joan Tosca, Pilar Aguilar, Pascual Medina, Paloma Lluch   +7 more
wiley   +1 more source

MINMON-J: a hybrid implementation pilot study evaluating a low-barrier hepatitis C treatment model in a jail setting. [PDF]

BMJ Open
Berk J, Fu ES, Murphy M, Akiyama MJ, Sulkowski M, Rich JD, Frank HE.   +6 more
europepmc   +1 more source

Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection

, 1997
Shinichi Kakumu, A OKUMARA, Tetsuya Ishikawa, K Iwata, Motoyoshi Yano, Kentaro Yoshioka   +5 more
openalex   +2 more sources